4.6 Article

Maintaining immune homeostasis with Coptis Chinensis water extract to mitigate sepsis severity via modulating gut microbiome and metabolism

Related references

Note: Only part of the references are listed.
Review Pediatrics

Mechanisms and modulation of sepsis-induced immune dysfunction in children

Leena B. Mithal et al.

Summary: Immunologic responses during sepsis vary significantly among patients and evolve over the course of illness, leading to a spectrum of immunoparalysis that can increase morbidity and mortality. Current research focuses on immune dysregulation and immunomodulatory therapies in sepsis, with future emphasis on personalized treatments involving gene expression.

PEDIATRIC RESEARCH (2022)

Article Multidisciplinary Sciences

A conserved Bacteroidetes antigen induces anti-inflammatory intestinal T lymphocytes

Djenet Bousbaine et al.

Summary: The microbiome plays a role in the development and maturation of the immune system. CD4(+) T cells in the intestine differentiate into different subtypes in response to commensal bacteria. The development of CD4IELs in the small intestine depends on the microbiota. Beta-hexosaminidase, a conserved enzyme in commensal bacteria, drives the differentiation of CD4IELs. In a mouse model of colitis, beta-hexosaminidase-specific lymphocytes protect against intestinal inflammation.

SCIENCE (2022)

Review Biochemistry & Molecular Biology

Proinflammatory cytokines levels in sepsis and healthy volunteers, and tumor necrosis factor-alpha associated sepsis mortality: A systematic review and meta-analysis

Amal A. Gharamti et al.

Summary: This study aimed to characterize levels of key inflammatory cytokines in sepsis patients, with a focus on TNFα, and found that elevated TNFα concentrations were associated with increased sepsis mortality rather than severity. These findings suggest a need to reevaluate the concept that elevated cytokines cause sepsis.

CYTOKINE (2022)

Review Immunology

Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway

Yuki Nakamori et al.

Summary: Sepsis is a disease characterized by a dysregulated host response to infection, with both inflammation and immune suppression occurring, and no specific treatment has been validated. The challenge lies in the complexity and heterogeneity of sepsis, requiring the selection of homogenous sepsis subgroups for testing experimental therapies. Artificial intelligence may help in identifying the most suitable subgroup for specific pathway inhibitors.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II-induced hypertension

Shan Jiang et al.

Summary: The study revealed that TMAO can enhance Ang II-induced hypertension and mediate Ang II-induced vasoconstriction, possibly through the PERK/ROS/CaMKII/PLC beta 3 pathway.

REDOX BIOLOGY (2021)

Article Critical Care Medicine

Paradox of trimethylamine-N-oxide, the impact of malnutrition on microbiota-derived metabolites and septic patients

Ruey-Hsing Chou et al.

Summary: The study found an inverse association between plasma TMAO concentration and non-cardiovascular death in septic shock patients. However, after adjusting for disease severity and nutritional status, TMAO concentration was no longer an independent predictor of non-cardiovascular death.

JOURNAL OF INTENSIVE CARE (2021)

Review Pharmacology & Pharmacy

Targeting Neutrophils in Sepsis: From Mechanism to Translation

Xiaofei Shen et al.

Summary: Sepsis is a life-threatening condition with a lack of specific treatment, and neutrophils play a crucial role during sepsis. Impairment in neutrophil function may lead to inappropriate responses to infection and increased susceptibility to secondary infection. Restoring neutrophil function could promote bacterial clearance and improve sepsis outcome.

FRONTIERS IN PHARMACOLOGY (2021)

Review Microbiology

The Controversial Role of Human Gut Lachnospiraceae

Mirco Vacca et al.

MICROORGANISMS (2020)

Review Critical Care Medicine

The gut microbiome's role in the development, maintenance, and outcomes of sepsis

Max W. Adelman et al.

CRITICAL CARE (2020)

Review Critical Care Medicine

Therapeutic Potential of the Gut Microbiota in the Management of Sepsis

Matteo Bassetti et al.

CRITICAL CARE (2020)

Review Primary Health Care

Antibiotic abuse during endodontic treatment: A contributing factor to antibiotic resistance

Ramta Bansal et al.

JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE (2019)

Review Gastroenterology & Hepatology

The role of the gut microbiota in sepsis

Bastiaan W. Haak et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)

Article Biochemistry & Molecular Biology

Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk

Weifei Zhu et al.

Review Critical Care Medicine

Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy

Anders Perner et al.

INTENSIVE CARE MEDICINE (2016)

Article Microbiology

Extreme Dysbiosis of the Microbiome in Critical Illness

Daniel McDonald et al.

MSPHERE (2016)

Review Gastroenterology & Hepatology

Role of the normal gut microbiota

Sai Manasa Jandhyala et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Review Microbiology

The gut microbiota, bacterial metabolites and colorectal cancer

Petra Louis et al.

NATURE REVIEWS MICROBIOLOGY (2014)

Article Biochemistry & Molecular Biology

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

Robert A. Koeth et al.

NATURE MEDICINE (2013)

Review Pharmacology & Pharmacy

Intestinal luminal nitrogen metabolism: Role of the gut microbiota and consequences for the host

Anne-Marie Davila et al.

PHARMACOLOGICAL RESEARCH (2013)

Article Biochemistry & Molecular Biology

Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota

Hachung Chung et al.

Review Critical Care Medicine

T CELLS ARE POTENT EARLY MEDIATORS OF THE HOST RESPONSE TO SEPSIS

Kevin R. Kasten et al.

SHOCK (2010)